← Back to Clinical Trials
Recruiting NCT02170155

NCT02170155 MRI-changes in Morphometry and Cerebro Spinale Fluid (CSF) Flow in Spinal Cord Disorders

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02170155
Status Recruiting
Phase
Sponsor University of Zurich
Condition Spinal Injury
Study Type OBSERVATIONAL
Enrollment 350 participants
Start Date 2012-12
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 350 participants in total. It began in 2012-12 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Understanding the onset and progression of spinal cord disorders is an important aim in clinical neurology. An early diagnosis with consequent therapy might prevent the progression of disability. Therefore, we aim to determine structural and dynamic changes in the microstructure of the spinal cord and CSF, and to explore the relationships between the MRI parameters, clinical disability, and electrophysiology. In some patients that undergo decompressive surgery CSF pressure will be measured invasive perioperative for 24h to find out if functional limitations and structural changes correlate with the spinal pressure and the spinal perfusion when the spinal cord is damaged.

Eligibility Criteria

Inclusion Criteria: * Cervical injury * Informed consent * Age 18-80 * CSM Exclusion Criteria: * No other neurologic disorder and psychiatric disorder * Seizure * MRI incompatibility * Pregnancy

Contact & Investigator

Central Contact

Patrick Freund, PhD

✉ patrick.freund@balgrist.ch

Frequently Asked Questions

Who can join the NCT02170155 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Spinal Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT02170155 currently recruiting?

Yes, NCT02170155 is actively recruiting participants. Contact the research team at patrick.freund@balgrist.ch for enrollment information.

Where is the NCT02170155 trial being conducted?

This trial is being conducted at Zurich, Switzerland.

Who is sponsoring the NCT02170155 clinical trial?

NCT02170155 is sponsored by University of Zurich. The trial plans to enroll 350 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology